Breaking News Instant updates and real-time market news.

AMRN

Amarin

$7.29 /

-0.175 (-2.35%)

, HKMPF

Hikma Pharmaceuticals

$0.00 /

+ (+0.00%)

07:51
05/22/20
05/22
07:51
05/22/20
07:51

COVID-19 trial validation of Vascepa's science, says Cantor Fitzgerald

Cantor Fitzgerald analyst Louise Chen views the clinical trial investigating the effects of Vascepa on inflammatory biomarkers and other patient outcomes in individuals with COVID-19 as a validation of the science behind Amarin's (AMRN) drug. The pilot study may provide more information on whether, how, and if icosapent ethyl has biological activity that could have beneficial effects in mitigating severity in COVID-19 infection, Chen tells investors in a research note. The analyst believes multiple mechanisms of action associated with Vascepa from clinical and mechanistic studies support the rationale to study its effects in patients with the COVID-19 infection. Chen keeps an Overweight rating on Amarin shares with a $35 price target. The stock in premarket trading is down 11% to $6.32 after Hikma Pharmaceuticals (HKMPF) announced overnight that it received approval from the Food and Drug Administration for its Icosapent Ethyl Capsules, the generic equivalent to Vascepa.

AMRN

Amarin

$7.29 /

-0.175 (-2.35%)

HKMPF

Hikma Pharmaceuticals

$0.00 /

+ (+0.00%)

AMRN Amarin
$7.29 /

-0.175 (-2.35%)

05/14/20 H.C. Wainwright
Patent attorney finds Amarin appeal brief effective, says H.C. Wainwright
05/05/20 Northland
Northland starts Amarin at Outperform amid 'major paradigm shift'
05/05/20
Fly Intel: Top five analyst initiations
05/05/20 Northland
Amarin initiated with an Outperform at Northland
HKMPF Hikma Pharmaceuticals
$0.00 /

+ (+0.00%)

04/28/20 Barclays
Hikma price target raised to 2,200 GBp from 1,950 GBp at Barclays
04/23/20 Goldman Sachs
Hikma Pharmaceuticals downgraded to Neutral from Buy at Goldman Sachs
04/16/20 Jefferies
Hikma Pharmaceuticals downgraded to Hold from Buy at Jefferies
03/31/20 Goldman Sachs
Goldman downgrades Amarin, cuts target to $4 from $27 after patent ruling

TODAY'S FREE FLY STORIES

Hot Stocks
Tyson says 326 of 1,604 team members tested positive for COVID at Texas plant » 13:10
05/29/20
05/29
13:10
05/29/20
13:10
TSN

Tyson Foods

$60.49 /

-1.32 (-2.14%)

Tyson Foods announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TSN Tyson Foods
$60.49 /

-1.32 (-2.14%)

TSN Tyson Foods
$60.49 /

-1.32 (-2.14%)

05/28/20
Fly Intel: Top five analyst downgrades
05/28/20 Argus
Tyson Foods downgraded to Hold from Buy at Argus
05/28/20 Argus
Tyson Foods downgraded to Hold from Buy at Argus
05/05/20
Fly Intel: Top five analyst downgrades
TSN Tyson Foods
$60.49 /

-1.32 (-2.14%)

TSN Tyson Foods
$60.49 /

-1.32 (-2.14%)

TSN Tyson Foods
$60.49 /

-1.32 (-2.14%)

TSN Tyson Foods
$60.49 /

-1.32 (-2.14%)

Recommendations
Adaptimmune data 'incrementally supportive,' but still early, says Mizuho » 13:09
05/29/20
05/29
13:09
05/29/20
13:09
ADAP

Adaptimmune

$11.51 /

+6.65 (+136.83%)

Mizuho analyst Mara…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADAP Adaptimmune
$11.51 /

+6.65 (+136.83%)

ADAP Adaptimmune
$11.51 /

+6.65 (+136.83%)

04/21/20 Mizuho
Adaptimmune initiated with a Neutral at Mizuho
10/23/19
Adaptimmune management to meet with SunTrust
08/02/19
Fly Intel: Top five analyst downgrades
08/02/19 Guggenheim
Adaptimmune downgraded to Neutral on low near-term visibility at Guggenheim
ADAP Adaptimmune
$11.51 /

+6.65 (+136.83%)

ADAP Adaptimmune
$11.51 /

+6.65 (+136.83%)

ADAP Adaptimmune
$11.51 /

+6.65 (+136.83%)

General News
NY Governor Cuomo reports 67 virus deaths vs. 74 deaths the day before » 13:08
05/29/20
05/29
13:08
05/29/20
13:08
SPY

SPDR S&P 500 ETF Trust

$300.46 /

-2.53 (-0.84%)

, SPX

S&P 500

$0.00 /

+ (+0.00%)

In his daily COVID-19…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SPY SPDR S&P 500 ETF Trust
$300.46 /

-2.53 (-0.84%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$300.46 /

-2.53 (-0.84%)

03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
02/27/20 Keefe Bruyette
Stock market may rally Monday on 'Biden bounce,' Keefe Bruyette says
02/24/20
Dow Jones futures decline over 800 points ahead of today's open
12/16/19 Piper Jaffray
Piper establishes 2020 S&P 500 price objective of 3,600
SPX S&P 500
$0.00 /

+ (+0.00%)

03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
02/27/20 Keefe Bruyette
Stock market may rally Monday on 'Biden bounce,' Keefe Bruyette says
02/24/20
Dow Jones futures decline over 800 points ahead of today's open
12/16/19 Piper Jaffray
Piper establishes 2020 S&P 500 price objective of 3,600
SPY SPDR S&P 500 ETF Trust
$300.46 /

-2.53 (-0.84%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$300.46 /

-2.53 (-0.84%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$300.46 /

-2.53 (-0.84%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$300.46 /

-2.53 (-0.84%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$300.46 /

-2.53 (-0.84%)

SPX S&P 500
$0.00 /

+ (+0.00%)

Hot Stocks
Wells Fargo names Kevin Reen CRO for consumer lending » 13:07
05/29/20
05/29
13:07
05/29/20
13:07
WFC

Wells Fargo

$26.27 /

-0.95 (-3.49%)

Wells Fargo announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WFC Wells Fargo
$26.27 /

-0.95 (-3.49%)

WFC Wells Fargo
$26.27 /

-0.95 (-3.49%)

10:09 Today
Fly Intel: Top five analyst initiations
07:37 Today
Wells Fargo initiated with a Neutral at DA Davidson
05/28/20 DA Davidson
Wells Fargo initiated with a Neutral at DA Davidson
05/15/20 Cowen
Cowen 'would be surprised' if Goldman tried to buy any big commercial banks
WFC Wells Fargo
$26.27 /

-0.95 (-3.49%)

WFC Wells Fargo
$26.27 /

-0.95 (-3.49%)

WFC Wells Fargo
$26.27 /

-0.95 (-3.49%)

WFC Wells Fargo
$26.27 /

-0.95 (-3.49%)

General news
Baker-Hughes Rig Count N. Amer. data reported » 13:06
05/29/20
05/29
13:06
05/29/20
13:06

Week of 5/29 Baker-Hughes…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
FX Action: USD-JPY » 13:05
05/29/20
05/29
13:05
05/29/20
13:05

FX Action: USD-JPY…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Baker Hughes reports U.S. rig count down 17 to 301 rigs » 13:04
05/29/20
05/29
13:04
05/29/20
13:04
BKR

Baker Hughes

$16.17 /

-0.23 (-1.40%)

Baker Hughes reports that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BKR Baker Hughes
$16.17 /

-0.23 (-1.40%)

BKR Baker Hughes
$16.17 /

-0.23 (-1.40%)

08:41 Today Northland
Baker Hughes initiated with a Market Perform at Northland
04/23/20 Citi
Baker Hughes price target raised to $16 from $14 at Citi
04/05/20 Bernstein
Baker Hughes upgraded to Outperform from Underperform at Bernstein
03/31/20
Fly Intel: Top five analyst downgrades
BKR Baker Hughes
$16.17 /

-0.23 (-1.40%)

BKR Baker Hughes
$16.17 /

-0.23 (-1.40%)

BKR Baker Hughes
$16.17 /

-0.23 (-1.40%)

Hot Stocks
Sen. Ted Cruz calls forTwitter to be investigated over Iran sanctions compliance » 13:03
05/29/20
05/29
13:03
05/29/20
13:03
TWTR

Twitter

$30.52 /

-1.08 (-3.42%)

Senator Ted Cruz has sent…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TWTR Twitter
$30.52 /

-1.08 (-3.42%)

TWTR Twitter
$30.52 /

-1.08 (-3.42%)

09:28 Today Baird
Twitter, Facebook pullbacks would likely be buying opportunities, says Baird
09:10 Today JPMorgan
Trump order may put 'overhang' on big tech in coming months, says JPMorgan
05/27/20 Cowen
Cowen says Twitter 'will be fine,' but Republicans could support Facebook suit
05/06/20 China Renaissance
Twitter price target lowered to $23 from $25 at China Renaissance
TWTR Twitter
$30.52 /

-1.08 (-3.42%)

TWTR Twitter
$30.52 /

-1.08 (-3.42%)

TWTR Twitter
$30.52 /

-1.08 (-3.42%)

TWTR Twitter
$30.52 /

-1.08 (-3.42%)

Hot Stocks
Baker Hughes reports U.S. rig count down 17 to 301 rigs  13:01
05/29/20
05/29
13:01
05/29/20
13:01
BKR

Baker Hughes

$16.15 /

-0.255 (-1.55%)

 
ShowHide Related Items >><<
BKR Baker Hughes
$16.15 /

-0.255 (-1.55%)

BKR Baker Hughes
$16.15 /

-0.255 (-1.55%)

08:41 Today Northland
Baker Hughes initiated with a Market Perform at Northland
04/23/20 Citi
Baker Hughes price target raised to $16 from $14 at Citi
04/05/20 Bernstein
Baker Hughes upgraded to Outperform from Underperform at Bernstein
03/31/20
Fly Intel: Top five analyst downgrades
BKR Baker Hughes
$16.15 /

-0.255 (-1.55%)

BKR Baker Hughes
$16.15 /

-0.255 (-1.55%)

BKR Baker Hughes
$16.15 /

-0.255 (-1.55%)

General news
Export Prices data reported. » 12:55
05/29/20
05/29
12:55
05/29/20
12:55

May Export Prices at % …

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
Import Prices data reported. » 12:55
05/29/20
05/29
12:55
05/29/20
12:55

May Import Prices at % …

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
EMA recommends approval of Johnson & Johnson Ebola vaccine » 12:55
05/29/20
05/29
12:55
05/29/20
12:55
JNJ

Johnson & Johnson

$146.31 /

-0.7 (-0.48%)

The European Medicines…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JNJ Johnson & Johnson
$146.31 /

-0.7 (-0.48%)

JNJ Johnson & Johnson
$146.31 /

-0.7 (-0.48%)

12:34 Today H.C. Wainwright
H.C. Wainwright sees path forward for Minerva's roluperidone despite setback
05/12/20 Oppenheimer
Novavax price target raised to $38.50 from $19 at Oppenheimer
04/29/20 Stephens
Catalent deal with J&J could represent $600M revenue opportunity, says Stephens
04/29/20 Barclays
Johnson & Johnson price target raised to $182 from $173 at Barclays
JNJ Johnson & Johnson
$146.31 /

-0.7 (-0.48%)

JNJ Johnson & Johnson
$146.31 /

-0.7 (-0.48%)

JNJ Johnson & Johnson
$146.31 /

-0.7 (-0.48%)

JNJ Johnson & Johnson
$146.31 /

-0.7 (-0.48%)

Periodicals
Sanofi halts recruitment of patients in hydroxychloroquine trials, Reuters says » 12:54
05/29/20
05/29
12:54
05/29/20
12:54
SNY

Sanofi

$48.41 /

-0.26 (-0.53%)

Sanofi is suspending…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNY Sanofi
$48.41 /

-0.26 (-0.53%)

SNY Sanofi
$48.41 /

-0.26 (-0.53%)

05/28/20 Piper Sandler
Alexion settlement could 'clear the deck' for acquirer, says Piper Sandler
05/27/20 Citi
BioMarin a good takeout candidate, but not by Sanofi, says Citi
05/26/20 UBS
Sanofi price target lowered to EUR 101 from EUR 103 at UBS
05/26/20 Piper Sandler
Piper remains buyer of Regeneron, ups target to $630 on buyback accretion
SNY Sanofi
$48.41 /

-0.26 (-0.53%)

SNY Sanofi
$48.41 /

-0.26 (-0.53%)

SNY Sanofi
$48.41 /

-0.26 (-0.53%)

SNY Sanofi
$48.41 /

-0.26 (-0.53%)

Options
Altimmune call volume above normal and directionally bullish » 12:45
05/29/20
05/29
12:45
05/29/20
12:45
ALT

Altimmune

$9.05 /

+0.93 (+11.45%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALT Altimmune
$9.05 /

+0.93 (+11.45%)

ALT Altimmune
$9.05 /

+0.93 (+11.45%)

05/06/20 Roth Capital
Novo data 'sets up the runway' for Altimmune, says Roth Capital
04/01/20
Roth Capital biotech analyst to hold an analyst/industry conference call
04/01/20
Roth Capital biotech analyst to hold an analyst/industry conference call
02/24/20
Fly Intel: Top five analyst initiations
ALT Altimmune
$9.05 /

+0.93 (+11.45%)

ALT Altimmune
$9.05 /

+0.93 (+11.45%)

ALT Altimmune
$9.05 /

+0.93 (+11.45%)

General news
Week of 5/29 Baker-Hughes Rig Count to be released at 13:00  12:45
05/29/20
05/29
12:45
05/29/20
12:45
 
Hot Stocks
Taubman jumps 3.5% to $41.98 after invite sent for Simon deal vote  12:41
05/29/20
05/29
12:41
05/29/20
12:41
TCO

Taubman Centers

$42.80 /

+2.29 (+5.65%)

, SPG

Simon Property

$56.77 /

-2.91 (-4.88%)

 
ShowHide Related Items >><<
TCO Taubman Centers
$42.80 /

+2.29 (+5.65%)

SPG Simon Property
$56.77 /

-2.91 (-4.88%)

TCO Taubman Centers
$42.80 /

+2.29 (+5.65%)

03/26/20 RBC Capital
Cheesecake, AMC news highlight tenants financial stress, says RBC Capital
03/02/20 Piper Sandler
Simon Property unlikely to back out of Taubman deal, says Piper Sandler
02/12/20 Piper Sandler
Macerich downgraded to Underweight from Neutral at Piper Sandler
02/11/20 Wells Fargo
Simon Property price target lowered to $168 from $182 at Wells Fargo
SPG Simon Property
$56.77 /

-2.91 (-4.88%)

05/07/20
Fly Intel: Top five analyst downgrades
05/07/20 Wells Fargo
Wells Fargo downgrades Simon Property, sees 'rocky' road to recovery for malls
05/07/20 Wells Fargo
Simon Property downgraded to Equal Weight from Overweight at Wells Fargo
04/14/20 BofA
BofA cuts Simon Property to Neutral amid 'unprecedented' retail challenges
TCO Taubman Centers
$42.80 /

+2.29 (+5.65%)

SPG Simon Property
$56.77 /

-2.91 (-4.88%)

TCO Taubman Centers
$42.80 /

+2.29 (+5.65%)

SPG Simon Property
$56.77 /

-2.91 (-4.88%)

TCO Taubman Centers
$42.80 /

+2.29 (+5.65%)

SPG Simon Property
$56.77 /

-2.91 (-4.88%)

SPG Simon Property
$56.77 /

-2.91 (-4.88%)

Periodicals
Morgan Stanley plans on returning some traders to office in June, CNBC reports » 12:39
05/29/20
05/29
12:39
05/29/20
12:39
MS

Morgan Stanley

$44.20 /

-0.2 (-0.45%)

Morgan Stanley is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MS Morgan Stanley
$44.20 /

-0.2 (-0.45%)

MS Morgan Stanley
$44.20 /

-0.2 (-0.45%)

05/21/20 Odeon Capital
Morgan Stanley upgraded to Buy from Hold at Odeon Capital
04/17/20 DA Davidson
Morgan Stanley price target raised to $42 from $35 at DA Davidson
04/17/20 BMO Capital
Morgan Stanley price target raised to $53 from $45 at BMO Capital
04/17/20 Oppenheimer
Morgan Stanley price target raised to $51 from $46 at Oppenheimer
MS Morgan Stanley
$44.20 /

-0.2 (-0.45%)

MS Morgan Stanley
$44.20 /

-0.2 (-0.45%)

MS Morgan Stanley
$44.20 /

-0.2 (-0.45%)

MS Morgan Stanley
$44.20 /

-0.2 (-0.45%)

Recommendations
H.C. Wainwright sees path forward for Minerva's roluperidone despite setback » 12:34
05/29/20
05/29
12:34
05/29/20
12:34
NERV

Minerva

$2.53 /

-10.95 (-81.23%)

, JNJ

Johnson & Johnson

$146.02 /

-0.99 (-0.67%)

H.C. Wainwright analyst…

H.C. Wainwright analyst Douglas Tsao maintains a Buy rating on Minerva Neurosciences (NERV) after roluperidone failed to achieve its primary endpoint in a Phase 3 trial for the treatment of the negative symptoms of schizophrenia. While it is not unusual for psychiatric drugs to experience clinical setbacks, it remains to be seen how the company proceeds, Tsao tells investors in a research note. The analyst continues to see "significant value" in seltorexant, which Minerva is co-developing with Johnson & Johnson's Janssen (JNJ) for the treatment of major depressive disorder with co-morbid insomnia. In addition, Tsao continues to see a path forward for roluperidone, noting "an additional study should not be too expensive." He keeps a $20 price target on Minerva shares pending the conference call on Monday. The stock in midday trading is down 80% to $2.68.

ShowHide Related Items >><<
NERV Minerva
$2.53 /

-10.95 (-81.23%)

JNJ Johnson & Johnson
$146.02 /

-0.99 (-0.67%)

NERV Minerva
$2.53 /

-10.95 (-81.23%)

12:28 Today William Blair
Minerva downgraded to Market Perform from Outperform at William Blair
05/14/20 BTIG
Minerva initiated with a Buy at BTIG
05/04/20 JMP Securities
JMP optimistic going into Minerva's Phase 3 schizophrenia readout
03/23/20 Citi
Sarepta, DBV among Citi's SMid Biotech picks amid coronavirus outbreak
JNJ Johnson & Johnson
$146.02 /

-0.99 (-0.67%)

05/12/20 Oppenheimer
Novavax price target raised to $38.50 from $19 at Oppenheimer
04/29/20 Stephens
Catalent deal with J&J could represent $600M revenue opportunity, says Stephens
04/29/20 Barclays
Johnson & Johnson price target raised to $182 from $173 at Barclays
04/28/20 UBS
Johnson & Johnson downgraded to Neutral from Buy at UBS
NERV Minerva
$2.53 /

-10.95 (-81.23%)

JNJ Johnson & Johnson
$146.02 /

-0.99 (-0.67%)

JNJ Johnson & Johnson
$146.02 /

-0.99 (-0.67%)

JNJ Johnson & Johnson
$146.02 /

-0.99 (-0.67%)

JNJ Johnson & Johnson
$146.02 /

-0.99 (-0.67%)

Periodicals
Beyond Meat products may be offered at KFCs in China in June, Barron's says » 12:32
05/29/20
05/29
12:32
05/29/20
12:32
BYND

Beyond Meat

$126.70 /

+5.91 (+4.89%)

, YUMC

Yum China

$44.43 /

+0.045 (+0.10%)

, DNKN

Dunkin' Brands

$64.48 /

-1.08 (-1.65%)

, MCD

McDonald's

$186.17 /

-0.15 (-0.08%)

, SBUX

Starbucks

$77.41 /

-1.13 (-1.44%)

Beyond Meat (BYND) is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BYND Beyond Meat
$126.70 /

+5.91 (+4.89%)

YUMC Yum China
$44.43 /

+0.045 (+0.10%)

DNKN Dunkin' Brands
$64.48 /

-1.08 (-1.65%)

MCD McDonald's
$186.17 /

-0.15 (-0.08%)

SBUX Starbucks
$77.41 /

-1.13 (-1.44%)

BYND Beyond Meat
$126.70 /

+5.91 (+4.89%)

05/19/20
Fly Intel: Top five analyst initiations
05/18/20 BTIG
Beyond Meat started with a Buy at BTIG on potential partnerships major chains
05/18/20 BTIG
Beyond Meat initiated with a Buy at BTIG
05/06/20 Goldman Sachs
Goldman Sachs reduces 2020-22 revenue estimates for Beyond Meat after Q1 report
YUMC Yum China
$44.43 /

+0.045 (+0.10%)

04/29/20 Daiwa
Yum China upgraded to Outperform from Neutral at Daiwa
02/06/20 Daiwa
Yum China downgraded to Hold from Outperform at Daiwa
10/28/19
Fly Intel: Top five analyst initiations
10/28/19 Jefferies
Yum China initiated with a Buy at Jefferies
DNKN Dunkin' Brands
$64.48 /

-1.08 (-1.65%)

05/18/20 BTIG
Beyond Meat started with a Buy at BTIG on potential partnerships major chains
05/01/20 BTIG
Dunkin' Brands price target raised to $70 from $60 at BTIG
05/01/20 RBC Capital
Dunkin' Brands price target raised to $68 from $60 at RBC Capital
04/27/20 Wells Fargo
Dunkin' Brands price target lowered to $63 from $71 at Wells Fargo
MCD McDonald's
$186.17 /

-0.15 (-0.08%)

05/26/20 JPMorgan
McDonald's price target raised to $180 from $172 at JPMorgan
05/26/20 JPMorgan
Chipotle price target raised to $845 from $630 at JPMorgan
05/26/20 Longbow
McDonald's price target raised to $210 from $197 at Longbow
05/18/20 BTIG
Beyond Meat started with a Buy at BTIG on potential partnerships major chains
SBUX Starbucks
$77.41 /

-1.13 (-1.44%)

05/28/20 Cleveland Research
Starbucks U.S. comp improvement to be moderate, says Cleveland Research
05/21/20 William Blair
Starbucks comps continuing to improve in both U.S. and China, says William Blair
05/21/20 Stephens
Starbucks tempered near-term expectations in update, says Stephens
05/18/20 BTIG
Beyond Meat started with a Buy at BTIG on potential partnerships major chains
BYND Beyond Meat
$126.70 /

+5.91 (+4.89%)

YUMC Yum China
$44.43 /

+0.045 (+0.10%)

DNKN Dunkin' Brands
$64.48 /

-1.08 (-1.65%)

MCD McDonald's
$186.17 /

-0.15 (-0.08%)

SBUX Starbucks
$77.41 /

-1.13 (-1.44%)

BYND Beyond Meat
$126.70 /

+5.91 (+4.89%)

YUMC Yum China
$44.43 /

+0.045 (+0.10%)

MCD McDonald's
$186.17 /

-0.15 (-0.08%)

SBUX Starbucks
$77.41 /

-1.13 (-1.44%)

BYND Beyond Meat
$126.70 /

+5.91 (+4.89%)

YUMC Yum China
$44.43 /

+0.045 (+0.10%)

DNKN Dunkin' Brands
$64.48 /

-1.08 (-1.65%)

MCD McDonald's
$186.17 /

-0.15 (-0.08%)

SBUX Starbucks
$77.41 /

-1.13 (-1.44%)

BYND Beyond Meat
$126.70 /

+5.91 (+4.89%)

YUMC Yum China
$44.43 /

+0.045 (+0.10%)

DNKN Dunkin' Brands
$64.48 /

-1.08 (-1.65%)

MCD McDonald's
$186.17 /

-0.15 (-0.08%)

SBUX Starbucks
$77.41 /

-1.13 (-1.44%)

General news
President Trump to hold press conference on China at 2pm ET  12:32
05/29/20
05/29
12:32
05/29/20
12:32
SPX

S&P 500

$0.00 /

+ (+0.00%)

, SPY

SPDR S&P 500 ETF Trust

$300.92 /

-2.07 (-0.68%)

 
ShowHide Related Items >><<
SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$300.92 /

-2.07 (-0.68%)

SPX S&P 500
$0.00 /

+ (+0.00%)

03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
02/27/20 Keefe Bruyette
Stock market may rally Monday on 'Biden bounce,' Keefe Bruyette says
02/24/20
Dow Jones futures decline over 800 points ahead of today's open
12/16/19 Piper Jaffray
Piper establishes 2020 S&P 500 price objective of 3,600
SPY SPDR S&P 500 ETF Trust
$300.92 /

-2.07 (-0.68%)

03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
02/27/20 Keefe Bruyette
Stock market may rally Monday on 'Biden bounce,' Keefe Bruyette says
02/24/20
Dow Jones futures decline over 800 points ahead of today's open
12/16/19 Piper Jaffray
Piper establishes 2020 S&P 500 price objective of 3,600
SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$300.92 /

-2.07 (-0.68%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$300.92 /

-2.07 (-0.68%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$300.92 /

-2.07 (-0.68%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$300.92 /

-2.07 (-0.68%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$300.92 /

-2.07 (-0.68%)

Downgrade
Minerva downgraded to Market Perform from Outperform at William Blair » 12:28
05/29/20
05/29
12:28
05/29/20
12:28
NERV

Minerva

$2.51 /

-10.97 (-81.38%)

William Blair analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NERV Minerva
$2.51 /

-10.97 (-81.38%)

NERV Minerva
$2.51 /

-10.97 (-81.38%)

05/14/20 BTIG
Minerva initiated with a Buy at BTIG
05/04/20 JMP Securities
JMP optimistic going into Minerva's Phase 3 schizophrenia readout
03/23/20 Citi
Sarepta, DBV among Citi's SMid Biotech picks amid coronavirus outbreak
12/19/19 JMP Securities
JMP maintains Outperform on Minerva, lowers target to $18 after MIN-117 failure
NERV Minerva
$2.51 /

-10.97 (-81.38%)

Conference/Events
Wolfe Research payments analyst to hold an analyst/industry webcast » 12:26
05/29/20
05/29
12:26
05/29/20
12:26

Payments, Processors…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
Menlo set up for 'successful' Q4 launch of Zilxi, says Cantor Fitzgerald » 12:26
05/29/20
05/29
12:26
05/29/20
12:26
MNLO

Menlo Therapeutics

$2.55 /

+0.035 (+1.39%)

After Menlo Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MNLO Menlo Therapeutics
$2.55 /

+0.035 (+1.39%)

MNLO Menlo Therapeutics
$2.55 /

+0.035 (+1.39%)

05/21/20 Northland
Menlo Therapeutics initiated with an Outperform at Northland
05/13/20 Barclays
Menlo Therapeutics price target raised to $3 from $2 at Barclays
05/12/20 H.C. Wainwright
Menlo Therapeutics price target raised to $2.50 from $2 at H.C. Wainwright
04/07/20 Barclays
Menlo Therapeutics price target lowered to $2 from $8 at Barclays
MNLO Menlo Therapeutics
$2.55 /

+0.035 (+1.39%)

MNLO Menlo Therapeutics
$2.55 /

+0.035 (+1.39%)

MNLO Menlo Therapeutics
$2.55 /

+0.035 (+1.39%)

Options
American Outdoor Brands call volume above normal and directionally bullish » 12:25
05/29/20
05/29
12:25
05/29/20
12:25
AOBC

American Outdoor Brands

$11.47 /

+0.675 (+6.25%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AOBC American Outdoor Brands
$11.47 /

+0.675 (+6.25%)

AOBC American Outdoor Brands
$11.47 /

+0.675 (+6.25%)

03/06/20 Lake Street
American Outdoor Brands price target lowered to $11.50 from $14 at Lake Street
11/14/19 Craig-Hallum
American Outdoor Brands price target raised to $12 from $10 at Craig-Hallum
10/09/19
Fly Intel: Top five analyst upgrades
10/09/19
American Outdoor Brands upgraded to Buy on valuation, catalysts at Craig-Hallum
AOBC American Outdoor Brands
$11.47 /

+0.675 (+6.25%)

AOBC American Outdoor Brands
$11.47 /

+0.675 (+6.25%)

AOBC American Outdoor Brands
$11.47 /

+0.675 (+6.25%)

AOBC American Outdoor Brands
$11.47 /

+0.675 (+6.25%)

Conference/Events
Karyopharm to hold a pharmaceutical update conference call » 12:25
05/29/20
05/29
12:25
05/29/20
12:25
KPTI

Karyopharm

$18.64 /

-0.16 (-0.85%)

Management discusses…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KPTI Karyopharm
$18.64 /

-0.16 (-0.85%)

KPTI Karyopharm
$18.64 /

-0.16 (-0.85%)

05/06/20 H.C. Wainwright
Karyopharm price target lowered to $40 from $43 at H.C. Wainwright
04/07/20 Wedbush
Wedbush sees signs of 'potential utility' for Karyopharm's selinexor for COVID
04/07/20 H.C. Wainwright
XPO1 inhibitors have shown promise as COVID-19 treatment, says H.C. Wainwright
03/04/20 Barclays
Karyopharm initiated with an Overweight at Barclays
KPTI Karyopharm
$18.64 /

-0.16 (-0.85%)

KPTI Karyopharm
$18.64 /

-0.16 (-0.85%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.